Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol

CONCLUSIONS: Panitumumab treatment provides limited CB in patients with recurrent RAF/RASwt glioblastoma precluding further development of this therapeutic strategy.PMID:38109296 | DOI:10.1093/oncolo/oyad320

Source: The Oncologist - December 18, 2023 Category: Cancer & Oncology Authors: Ilse A C Spiekman Birgit S Geurts Laurien J Zeverijn Gijs F de Wit Vincent van der Noort Paul Roepman Wendy W J de Leng Anne M L Jansen Benno Kusters Laurens V Beerepoot Filip Y F L de Vos Derk-Jan A de Groot Jan Willem B de Groot Ann Hoeben Jan Buter Han Source Type: research